Tony Ho is a Senior Science Partner at Pivotal Life Sciences. He previously held leadership roles in research and development at CRISPR Therapeutics, AstraZeneca, and Merck.
One email when Tony's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckTony Ho is a Senior Science Partner at Pivotal Life Sciences. He previously held leadership roles in research and development at CRISPR Therapeutics, AstraZeneca, and Merck.
Pivotal Life Sciences has not reported a check size.
A warm intro from a founder Pivotal Life Sciences backed works best.
Co-Founder and CSO at Neuronyx; head of Neurology and Ophthalmology at Merck; SVP and Head of Oncology Integration and Innovation at AstraZeneca; Executive Vice President, Head of Research and Development at Crispr Therapeutics.
Last updated 2026-10-15. Is this you? Ask for a correction.